The kit initially included three autoinjectors containing an anti-motion sickness medication, a stimulant, and a vasoconstrictor for treating shock
Myth: You need a refrigerated travel bag for all GLP-1 medications
Weight loss results In a 2022 review of 22 studies that included more than 17,000 people with or without type 2 diabetes treated with semaglutide or liraglutide: More than 50% of participants treated with either semaglutide or liraglutide lost 5% or more of their starting weight after an average of 39 weeks on the medicine About 17% of participants lost 10% or more of their body weight in the same period A phase 3 clinical trial studied treatment with tirzepatide in people with obesity and found that it produced substantial and sustained weight loss at various dose strengths
Richard Pratley, Translational Research Institute, AdventHealth, Orlando, FL, USA
People with longstanding type 2 diabetes often have more advanced beta cell dysfunction and may respond less robustly to GLP-1 therapy
While there is some uncertainty, consult a health professional for suitability and safety